162
Participants
Start Date
March 31, 2016
Primary Completion Date
April 30, 2024
Study Completion Date
November 8, 2024
Bland Embolization
Lobar or segmental bland embolization with microspheres (50-500 microns) to 2-5 heartbeat stasis
Transarterial chemoembolization
Lobar or segmental lipiodol transarterial chemoembolization. Doxorubicin 50 mg dissolved in 10 mL dilute contrast and emulsified with 10-20 cc iodized oil, followed by 50-500 μm microspheres.
Drug Eluting Beads Embolization
CLOSED - Lobar or segmental hepatic chemoembolization with DEBDOX (100-300 or 300-500 micron beads loaded with doxorubicin per manufacturer IFU.
Mount Sinai School of Medicine, New York
Memorial Sloan Kettering Cancer Center, New York
University of Pittsburgh Medical Center, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Ospedale San Raffaele, Milan
Moffitt Cancer Center, Tampa
Medical College of Wisconsin, Milwaukee
MD Anderson Cancer Center, Houston
University of California San Francisco, San Francisco
Stanford University, Standford
Oregon Health & Science University, Portland
Hospital Italiano de Buenos Aires, Buenos Aires
Sunnybrook Health Sciences Centre, Toronto
Collaborators (1)
Guerbet
INDUSTRY
Abramson Cancer Center at Penn Medicine
OTHER